Phase III multicenter randomized trial of the Dartmouth regimen ...

Melanoma Publications - Hoosier Cancer Research Network

A Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine Alone in Patients with Metastatic Melanoma: A MSK ...

Phase II Trial of Karenitecin in Patients with Malignant Melanoma

Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol. 1999. ;. 17. : 2745. –51 ...

Phase III multicenter randomized trial of the Dartmouth regimen ...

Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. 論文の日本語タイトル. 診療ｶﾞｲﾄﾞﾗｲﾝ ...

Phase II study of second-line therapy with DTIC, BCNU - CiteSeerX

One of the most widely used is DTIC, BCNU, cisplatin and tamoxifen (DBPT) – the Dartmouth regimen. ... and Gore ME (1998) Randomized phase II trial of BCDT [ ...

Re-evaluating the role of dacarbazine in metastatic melanoma

10. Chapman, P.B ∙ Einhorn, L.H ∙ Meyers, M.L ... Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic ...

Biochemotherapy with Carmustine, Cisplatin, Dacarbazine ...

Phase III multicenter randomized trial of the. Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol 1999;17:2745-51. 6 ...

Phase III randomized study of fotemustine and dacarbazine versus ...

In the adjuvant setting, a meta-analysis of randomized melanoma trials using a wide range of IFN dose regimens revealed that the benefits of IFN ...

Carmustine, Cisplatin, Dacarbazine, and Tamoxifen (Dartmouth ...

17(6):1884-1890. 11. Chapman PB, Einhorn LH, Meyers. ML, et al. Phase 3 multicenter random-. ized trial of the Dartmouth regimen ver-. sus ...

‪Paul Chapman‬ - ‪Google Scholar‬

Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. PB Chapman, LH Einhorn, ML Meyers, S ...

Synta Presents Results for STA-4783 in Metastatic Melanoma ...

-- Chapman PB, et al: Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic ...

American Society of Clinical Oncology - Synapse

Author ascending is default. ← Previous 1 2 3 4 5 6 7 8 9 10 11 12 Next →. Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in ...

Phase II Trial Of Intravesical Gemcitabine And Mk-3475 ...

This phase II trial studies the effect of adding pembrolizumab to gemcitabine in treating patients with non-muscle invasive bladder cancer whose cancer does ...

Carmustine, Cisplatin, Dacarbazine, and Tamoxifen (Dartmouth ...

Phase 3 multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol. 1999; 17(9): 2745–2751 ...

A phase III randomized trial with or without Consolidation ...

This study is multinational, multicenter, phase III randomized trial to determine the efficacy of consolidation chemotherapy with docetaxel and cisplatin ...

Management of Metastatic Cutaneous Melanoma - Cancer Network

3 The randomized phase 2 PASS-01 trial (NCT04469556) compared these regimens head-to-head in 140 patients with de novo metastatic PDAC (mPDAC).

Results of systemic treatment of cutaneous melanoma in inoperable ...

Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol 1999 ...

Phase III multicenter randomized trial of the Dartmouth regimen ...

Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. 被引用文献3件.

Melanoma vaccines: Are we making any progress? - Healio

Data from a multicenter phase-3 clinical trial, in which the researchers compared Melacine with the Dartmouth regimen (dacarbazine, cisplatin, ...

Systemic Therapies for Advanced Melanoma - Dermatologic Clinics

Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol. 1999 ...

NCCP Chemotherapy Regimen - Dacarbazine Therapy - HSE.ie

Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol 1999 ...